No abstract available
Publication types
-
Comment
-
Comparative Study
-
Letter
MeSH terms
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Choroidal Neovascularization / drug therapy*
-
Choroidal Neovascularization / etiology
-
Fluorescein Angiography
-
Fovea Centralis / drug effects
-
Humans
-
Injections
-
Myopia, Degenerative / complications*
-
Randomized Controlled Trials as Topic
-
Ranibizumab
-
Tomography, Optical Coherence
-
Treatment Outcome
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / drug effects
-
Vitreous Body
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab
-
Ranibizumab